Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.

نویسندگان

  • Petter S Woll
  • Una Kjällquist
  • Onima Chowdhury
  • Helen Doolittle
  • David C Wedge
  • Supat Thongjuea
  • Rikard Erlandsson
  • Mtakai Ngara
  • Kristina Anderson
  • Qiaolin Deng
  • Adam J Mead
  • Laura Stenson
  • Alice Giustacchini
  • Sara Duarte
  • Eleni Giannoulatou
  • Stephen Taylor
  • Mohsen Karimi
  • Christian Scharenberg
  • Teresa Mortera-Blanco
  • Iain C Macaulay
  • Sally-Ann Clark
  • Ingunn Dybedal
  • Dag Josefsen
  • Pierre Fenaux
  • Peter Hokland
  • Mette S Holm
  • Mario Cazzola
  • Luca Malcovati
  • Sudhir Tauro
  • David Bowen
  • Jacqueline Boultwood
  • Andrea Pellagatti
  • John E Pimanda
  • Ashwin Unnikrishnan
  • Paresh Vyas
  • Gudrun Göhring
  • Brigitte Schlegelberger
  • Magnus Tobiasson
  • Gunnar Kvalheim
  • Stefan N Constantinescu
  • Claus Nerlov
  • Lars Nilsson
  • Peter J Campbell
  • Rickard Sandberg
  • Elli Papaemmanuil
  • Eva Hellström-Lindberg
  • Sten Linnarsson
  • Sten Eirik W Jacobsen
چکیده

Evidence for distinct human cancer stem cells (CSCs) remains contentious and the degree to which different cancer cells contribute to propagating malignancies in patients remains unexplored. In low- to intermediate-risk myelodysplastic syndromes (MDS), we establish the existence of rare multipotent MDS stem cells (MDS-SCs), and their hierarchical relationship to lineage-restricted MDS progenitors. All identified somatically acquired genetic lesions were backtracked to distinct MDS-SCs, establishing their distinct MDS-propagating function in vivo. In isolated del(5q)-MDS, acquisition of del(5q) preceded diverse recurrent driver mutations. Sequential analysis in del(5q)-MDS revealed genetic evolution in MDS-SCs and MDS-progenitors prior to leukemic transformation. These findings provide definitive evidence for rare human MDS-SCs in vivo, with extensive implications for the targeting of the cells required and sufficient for MDS-propagation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Isolation and in vitro Characterization of Mesenchymal Stem Cells Derived from the Pulp Tissue of Human Third Molar Tooth

Background: It is still controversial that the stem cells isolated from human dental pulp meets the criteria for mesenchymal stem cells (MSCs). The aim of the present study was to examine whether or not they are MSCs, or are distinct stem cells population residing in tooth pulp. Methods: Adherent fibroblastic cells in the culture of pulp tissue from human third molars were propagated through se...

متن کامل

Cancer stem cells: therapeutic targets

Cancer stem cells (CSCs) have been identified as rare cellular populations in many cancers, including leukemia and solid tumors. This minor subpopulation of cancerous cells is immortal tumor-initiating cells which thought to be responsible for cancer initiation, progression, metastasis, recurrence and drug/radiation resistance. Low proliferative rate, high self-renewing capacity, differentiatio...

متن کامل

Tumorigenicity of Esophageal Cancer Stem Cells (ECSCs) in nude mouse xenograft model

Background and objectives: Modeling cancer in vivo is a very important tool to investigate cancer pathogenesis and molecular mechanisms involved in cancer progression. Laboratory mice are the most common animal used for rebuilding human cancer in vivo. Cancer stem cells (CSCs) are the main reason of failure in cancer therapy because of tumor relapse and metastasis. Isolation of cancer stem cell...

متن کامل

Supernatant Metabolites from Halophilic Archaea to Reduce Tumorigenesis in Prostate Cancer In-vitro and In-vivo

Halophilic archaea are known as the novel producers of natural products and their supernatant metabolites could have cytotoxic effects on cancer cells. In the present study, we screened the anticancer potential of supernatant metabolites from eight native haloarchaeal strains obtained from a culture collection in Iran. Five human cancer cell lines including breast, lung, prostate and also human...

متن کامل

Human Wharton’s jelly mesenchymal stem cells-derived secretome could inhibit breast cancer growth in vitro and in vivo

Objective(s): Controversial results have been reported regarding the anti-tumor properties of extracellular vesicles derived from mesenchymal stem cells (MSCs). The present study was conducted to evaluate whether secretome derived from Human Wharton’s jelly mesenchymal stem cells (hWJMSCs) may stimulate or inhibit breast cancer growth in vitro and in vivo.<st...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Cancer cell

دوره 25 6  شماره 

صفحات  -

تاریخ انتشار 2014